Actively Recruiting
Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders
Led by The University of Texas Health Science Center, Houston · Updated on 2024-12-30
60
Participants Needed
1
Research Sites
155 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to test an addiction-clinic based behavioral intervention for increasing PrEP uptake and adherence among women who engage in high-risk sexual behaviors and problematic substance use. The main question it aims to answer is: • If the integrated intervention increase PrEP uptake and adherence compared to standard treatment Participants will * receive provision of PrEP information through 4 counseling sessions * prevention navigation * receive nurse practitioner prescribed PrEP in an addiction treatment setting Researchers will compare intervention group with standard treatment to see if the integrated intervention help increase PrEP uptake and adherence
CONDITIONS
Official Title
Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Black/African American and Hispanic/Latina cisgender women
- Diagnosed with a Substance Use Disorder (SUD) according to DSM-5 criteria
- HIV negative
- Sexually active with an opposite sex partner within the past 6 months
- Not currently using PrEP for HIV prevention
- Able to speak, read, and write in English
- Own or have regular access to a smartphone
You will not qualify if you...
- Currently participating in another SUD behavioral treatment program
- Unable to provide informed consent (e.g., severe cognitive impairment)
- Experiencing psychological distress that prevents study participation
- Unable or unwilling to meet study requirements
- Ineligible for PrEP based on CDC criteria for substance use and sexual risk
- Have medical contraindications for PrEP, such as known renal impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston
Houston, Texas, United States, 77054
Actively Recruiting
Research Team
A
Angela Heads, PhD
CONTACT
K
Kaixuan An
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here